Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |